当前位置: X-MOL 学术Nat. Med. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Author Correction: Targeting wild-type KRAS-amplified gastroesophageal cancer through combined MEK and SHP2 inhibition.
Nature Medicine ( IF 82.9 ) Pub Date : 2018-Oct-01 , DOI: 10.1038/s41591-018-0168-6
Gabrielle S Wong 1, 2 , Jin Zhou 1 , Jie Bin Liu 1 , Zhong Wu 1 , Xinsen Xu 1 , Tianxia Li 1 , David Xu 3 , Steven E Schumacher 4 , Jens Puschhof 1 , James McFarland 1, 4 , Charles Zou 1 , Austin Dulak 1, 5 , Les Henderson 3 , Peng Xu 3 , Emily O'Day 3 , Rachel Rendak 3 , Wei-Li Liao 6 , Fabiola Cecchi 6 , Todd Hembrough 6 , Sarit Schwartz 6 , Christopher Szeto 6 , Anil K Rustgi 7 , Kwok-Kin Wong 8, 9 , J Alan Diehl 10 , Karin Jensen 11, 12 , Francesco Graziano 13 , Annamaria Ruzzo 13 , Shaunt Fereshetian 4 , Philipp Mertins 4, 14 , Steven A Carr 4 , Rameen Beroukhim 1, 4, 8, 15, 16 , Kenichi Nakamura 17 , Eiji Oki 18 , Masayuki Watanabe 17, 19 , Hideo Baba 17 , Yu Imamura 17, 19 , Daniel Catenacci 3 , Adam J Bass 1, 4, 8, 15
Affiliation  

In the Supplementary Information originally published with this article, a lane was missing in the β-actin blot in Supplementary Fig. 2. The lane has been added. The error has been corrected in the Supplementary Information associated with this article.

中文翻译:

作者更正:通过结合 MEK 和 SHP2 抑制来靶向野生型 KRAS 扩增的胃食管癌。

在最初与本文一起发布的补充信息中,补充图 2 中的 β-肌动蛋白印迹中缺少一条泳道。该泳道已添加。该错误已在与本文相关的补充信息中得到纠正。
更新日期:2018-08-10
down
wechat
bug